Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $7.63M. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −93.6% to −34.3% across the middle 80 percent of the group, with a median of −83.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| SERA | Sera Prognostics, Inc. | $86.00M | Micro cap | −17.42% | Nov 16, 2026 |
| MDXH | MDxHealth SA | $70.73M | Micro cap | −83.84% | Nov 12, 2026 |
| PAVM | PAVmed Inc. | $40.78M | Micro cap | −64.04% | Nov 12, 2026 |
| CODX | Co-Diagnostics, Inc. | $7.63M | Micro cap | −87.07% | Nov 16, 2026 |
| CDIO | Cardio Diagnostics Holdings, Inc. | $5.65M | Micro cap | −45.58% | Nov 6, 2026 |
| VNRX | VolitionRx Limited | $5.25M | Micro cap | −97.21% | Nov 12, 2026 |
| REVB | Revelation Biosciences, Inc. | $3.98M | Micro cap | −91.21% | Nov 5, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.